$BCTX Phase 3 breast cancer trial adding NYU Langone’s Perlmutter Cancer Center as a clinical site supporting development of a novel immunotherapy for advanced disease.
NEWS: https://bit.ly/4naW9PK
#Biotech #Healthcare #Oncology #ClinicalTrials #BreastCancer #ClinicalResearch